You are here: Industry Insights > formulation

News List

Revealed structure of glucagon fibrils could improve drug formulation europeanpharmaceuticalreview
June 28, 2019
Researchers have discovered the formulation of glucagon fibrils, which could inform drug formulation for diabetic patients.
Discover Roquette’s latest biopharmaceutical innovations and our 360° digital experience europeanpharmaceuticalreview
April 18, 2019
Learn how Roquette supports customers in the development of innovative pharmaceutical formulations and new biopharma solutions…
Aprecia, CMIC Enter 3DP Pact in Japan contractpharma
March 08, 2019
Will leverage Aprecia’s ZipDose Technology for product license, development, manufacturing, and distribution partnerships.
Catalent Invests $27M to Commercialize Zydis Ultra contractpharma
March 08, 2019
ODT technology enables the dosage of active ingredient up to four times higher than conventional Zydis ODT.
ReForm Biologics, Astellas Form Collaboration contractpharma
March 07, 2019
Will use ReForm’s technology to help progress Astellas’ biologics pipeline
Merck’s formulation steps further for approval in 21 EU countries biospectrumasia
July 30, 2018
BfArM is acting as a representative of all 21 EU countries involved in the EU worksharing procedure
Brilique (ticagrelor) new formulation gains European approval europeanpharmaceuticalreview
May 26, 2017
The European Commission (EC) has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new method of treatment administration.
Debiopharm’s triptorelin 6-month formulation receives EU approval europeanpharmaceuticalreview
March 21, 2017
Debiopharm International received approval for the treatment of central precocious puberty (CPP) in 22 European countries.

Previous page 1 2 Next page